{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:54:30Z","timestamp":1775933670598,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020141","name":"Akebia Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jacl.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:38:07Z","timestamp":1694234287000},"page":"777-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-8905","authenticated-orcid":false,"given":"Emilio","family":"Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-8112","authenticated-orcid":false,"given":"Bogdan","family":"Vlacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray Puig","family":"Treserres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-3622","authenticated-orcid":false,"given":"Manel","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreu","family":"Altes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2868-0250","authenticated-orcid":false,"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2023.09.002_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2023.09.002_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12944-016-0251-2","article-title":"Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain","volume":"15","author":"Lamiquiz-Moneo","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2023.09.002_bib0003","doi-asserted-by":"crossref","first-page":"m3109","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jacl.2023.09.002_bib0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2016.02.019","article-title":"Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system","volume":"10","author":"Rashid","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2023.09.002_bib0005","first-page":"310","volume":"19","author":"Pejic","year":"2006","journal-title":"Hypertriglyceridemia"},{"issue":"9943","key":"10.1016\/j.jacl.2023.09.002_bib0006","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.jacl.2023.09.002_bib0007","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","article-title":"Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease","volume":"36","author":"Varbo","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jacl.2023.09.002_bib0008","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13696998.2017.1284078","article-title":"Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context","volume":"20","author":"Toth","year":"2017","journal-title":"J Med Econ"},{"key":"10.1016\/j.jacl.2023.09.002_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-017-0511-9","article-title":"Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics","volume":"16","author":"Retterst\u00f8l","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.jacl.2023.09.002_bib0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2,000mg\/dl) hypertriglyceridemia in United States adults","volume":"107","author":"Christian","year":"2011","journal-title":"Amer J Cardiol"},{"key":"10.1016\/j.jacl.2023.09.002_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12933-015-0268-2","article-title":"PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia","volume":"14","author":"Karpov","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2023.09.002_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-021-01517-6","article-title":"Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study","volume":"20","author":"Berberich","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2023.09.002_bib0013","series-title":"Archives of Cardiovascular Diseases Supplements","first-page":"118","article-title":"Big Data and severe hypertriglyceridemia: prevalence in 297,909 individuals","author":"Ferri\u00e8res","year":"2019"},{"issue":"4","key":"10.1016\/j.jacl.2023.09.002_bib0014","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00157394","article-title":"Epidemiology of cardiovascular disease risk factors in Catalonia (Spain)","volume":"9","author":"Plans","year":"1993","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.002_bib0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.atherosclerosis.2009.05.024","article-title":"Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study","volume":"207","author":"Valdivielso","year":"2009","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacl.2023.09.002_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.arteri.2020.04.001","article-title":"Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study","volume":"32","author":"Ruiz-garc\u00eda","year":"2020","journal-title":"Cl\u00edn Investig Arterioscler"},{"key":"10.1016\/j.jacl.2023.09.002_bib0017","unstructured":"Council for International Organizations of Medical Sciences. International Guidelines For Ethical Review of Epidemiological Studies. 1991."},{"issue":"20","key":"10.1016\/j.jacl.2023.09.002_bib0018","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jacl.2023.09.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacl.2023.09.002_bib0020","unstructured":"Instituto de Estad\u00edstica de Catalu\u00f1a. Poblaci\u00f3n a 1 de enero. Por Sexo [Population on January, 1. By sex] [Internet]. 2020 [cited 2022 Nov 8]. Available from: https:\/\/www.idescat.cat\/indicadors\/?id=anuals&n=10328&lang=es&t=201900."},{"issue":"9","key":"10.1016\/j.jacl.2023.09.002_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.endonu.2016.07.004","article-title":"Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain","volume":"63","author":"Mata-Cases","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.jacl.2023.09.002_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12933-021-01323-5","article-title":"Cardiovascular and mortality benefits of sodium\u2013glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia","volume":"20","author":"Real","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2023.09.002_bib0023","article-title":"All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: a comparative, trend analysis in Canada, Spain, and the UK","author":"Ling","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacl.2023.09.002_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.810757","article-title":"Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in Catalonia during 2007\u20132018","volume":"12","author":"Mata-Cases","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jacl.2023.09.002_bib0025","series-title":"International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)","year":"2022"},{"key":"10.1016\/j.jacl.2023.09.002_bib0026","series-title":"CIM-10-MC\/SCP [Internet]","year":"2022"},{"issue":"3","key":"10.1016\/j.jacl.2023.09.002_bib0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1157\/13123961","article-title":"Construcci\u00f3n de un \u00edndice de privaci\u00f3n a partir de datos censales en grandes ciudades espa\u00f1olas (Proyecto MEDEA)","volume":"22","author":"Dom\u00ednguez-Berj\u00f3n","year":"2008","journal-title":"Gac Sanit"},{"key":"10.1016\/j.jacl.2023.09.002_bib0028","series-title":"R: A Language and Environment For Statistical Computing","year":"2021"},{"issue":"4","key":"10.1016\/j.jacl.2023.09.002_bib0029","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacl.2018.03.086","article-title":"Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service","volume":"12","author":"Zafrir","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.002_bib0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pan.2021.02.005","article-title":"Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study","volume":"21","author":"Schou Olesen","year":"2021","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.jacl.2023.09.002_bib0031","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jacl.2019.09.005","article-title":"A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis","volume":"13","author":"Jin","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"8","key":"10.1016\/j.jacl.2023.09.002_bib0032","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jacl.2023.09.002_bib0033","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","volume":"10","author":"Sandhu","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"21","key":"10.1016\/j.jacl.2023.09.002_bib0034","doi-asserted-by":"crossref","first-page":"e25983","DOI":"10.1097\/MD.0000000000025983","article-title":"Factors associated with the severity of hypertriglyceridemia induced acute pancreatitis","volume":"100","author":"Thong","year":"2021","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.jacl.2023.09.002_bib0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2019.08.002","article-title":"Subsets associated with developing acute pancreatitis in patients with severe hypertriglyceridemia and the severity of pancreatitis","volume":"19","author":"Jo","year":"2019","journal-title":"Pancreatology"},{"issue":"12","key":"10.1016\/j.jacl.2023.09.002_bib0036","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.3390\/jcm9123954","article-title":"Incidence and management of hypertriglyceridemia-associated acute pancreatitis: a prospective case series in a single Australian tertiary centre","volume":"9","author":"Evelyn Tan","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.jacl.2023.09.002_bib0037","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjms.2021.01.005","article-title":"Secondary causes of hypertriglyceridemia are prevalent among patients presenting with hypertriglyceridemia induced acute pancreatitis","volume":"361","author":"Qureshi","year":"2021","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jacl.2023.09.002_bib0038","article-title":"Diabetes and younger age are vital and independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"issue":"12","key":"10.1016\/j.jacl.2023.09.002_bib0039","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.numecd.2015.09.007","article-title":"Lower-normal TSH is associated with better metabolic risk factors: a cross-sectional study on Spanish men","volume":"25","author":"Laclaustra","year":"2015","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2023.09.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/818570","article-title":"Gamma-Glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk","author":"Koenig","year":"2015","journal-title":"Dis Markers"},{"issue":"7","key":"10.1016\/j.jacl.2023.09.002_bib0041","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1440-1746.2009.05831.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population","volume":"24","author":"Dassanayake","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jacl.2023.09.002_bib0042","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","article-title":"Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures","volume":"26","author":"Zelber-Sagi","year":"2006","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.jacl.2023.09.002_bib0043","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2009-0814","article-title":"Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia","volume":"94","author":"Solanas-Barca","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-12-365","article-title":"Monitoring the prevalence of chronic conditions: which data should we use?","volume":"12","author":"Orueta","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-251","article-title":"Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity","volume":"13","author":"Viol\u00e1n","year":"2013","journal-title":"BMC Public Health"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:38:58Z","timestamp":1761831538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423002635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1933287423002635"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}